Role Description
The Senior Director, HEOR/RWE is a leader within the organization, responsible for developing an HEOR/RWE strategy and executing HEOR plans and activities related to Revolution Medicines assets intended for use in pancreatic and colorectal cancer. They will be accountable for demonstrating the value of Revolution Medicines products to healthcare organizations, allowing them to make informed decisions. They will work closely with the Medical Affairs team as well as other cross-functional teams to optimize the Integrated Evidence Plan (IEP) and to deliver evidence supporting the use of Revolution Medicines products. This individual will serve as an HEOR expert internally and also while representing RevMed externally at industry conferences.
Reporting to the Executive Director of HEOR/RWE GI, the Senior Director, HEOR/RWE will:
-
Develop and evolve product HEOR/RWE strategy, including integration with development and market access planning.
-
Align with Medical Affairs and Development leadership to design research and deliver evidence consistent with the medical strategy and IEP.
-
Deliver HEOR/RWE tactics with quality and in alignment with agreed upon timing.
-
Provide HEOR/RWE leadership on matrix teams and working groups.
-
Lead enterprise partnerships with payers, HTA agencies, and global consortia to help shape access strategy, policies, evidence standards, and evidence generation activities.
-
Work with the HEOR/RWE and Medical Affairs leadership to ensure critical value insights are communicated to key internal teams.
-
Provide HEOR evidence which addresses the needs and expectations of key stakeholders such as patients, healthcare providers, payers and Health Technology Assessment (HTA) agencies.
-
Effectively present research findings to internal and external stakeholders to improve internal decision making and to promote wider adoption of research findings across external stakeholders.
-
Facilitate the communication of the value proposition of Revolution Medicinesβ portfolio, allowing key healthcare and formulary professionals to make informed therapeutic decisions.
-
Engage and collaborate with external partners including payers, health care providers, thought leaders, patient advocates, and decision-makers to establish/maintain strong partnerships and gather insights into research programs.
-
Facilitate and implement real-world research partnership engagements with leading healthcare, academic and payer organizations to co-create value evidence and help drive evidence-based optimal care.
-
Stay up to date with and add to the advancements in health economics methodologies and best practices; support the build of disease area HEOR/RWE disease area capability, establishing best practices, external visibility, and functional excellence across the medical affairs network.
-
Identify and interface with HEOR & RWE experts and organizations, profile data sources and related organizations as they relate to Revolution Medicinesβ portfolio and therapeutic areas.
-
Closely monitor new trends in health policy and payer environment, assess competitive data gaps and communicate to the organization, to help Revolution Medicines build industry-leading capabilities and be on the cutting edge of evidence-based medicine and HEOR research.
Qualifications
-
Deep expertise in health economics, outcomes research, patient-reported outcomes or related fields in the biotechnology or pharmaceutical industry.
-
Experience in oncology HEOR and RWE development.
-
Minimum 10-13 years of relevant experience with an advanced degree in a relevant field (MD, PhD, PharmD).
-
Track record of high impact publications in HEOR/RWE topics.
-
Proven success influencing payer/HTA strategy and incorporating HEOR considerations into clinical development programs.
-
Strong written and interpersonal communication skills, with an ability to present complex technical information clearly.
-
Demonstrated ability to lead evidence generation initiatives and to communicate HEOR value to internal senior leadership and external decision-makers.
-
Knowledge and experience in managed care, integrated delivery networks, formulary decision-making, and payment/access models.
-
Ability to establish relationships with experts in real world evidence (RWE) and therapeutic areas of interest.
Preferred Skills
-
10+ years of relevant experience in the pharmaceutical/biotech industry.
-
Global launch experience.
-
Experience related to gastrointestinal oncology.